Mechanism of Action
Overview of the pathophysiology of Multiple Sclerosis and the mechanism of action of cladribine | Video
eMedI Chat
eMedI Chat 
Patient Resources
Research
Additional Neurology Resources
- National Multiple Sclerosis Society
- Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
- American Academy of Neurology (AAN)
- Consortium of Multiple Sclerosis Centers (CMSC)
- European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
- Press Releases
MS LifeLines and MAVENCLAD are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
This site is intended for US healthcare professionals only.
DISCLAIMER: This site contains medical information that is intended for healthcare providers of the United States only. The medical information contained on this site is not meant to substitute for the advice provided by a medical professional. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.
EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada.
US-MULNP-00046 1/26
© 2026 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved.